← Back to Search

Other

micro dose icg for Perfusion Complications

N/A

Recruiting

Research Sponsored by Shanglei Liu

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients undergoing intestinal resection surgery

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 30 days post operatively

Awards & highlights

Study Summary

This trial is comparing the use of small doses of ICG (a fluorescent dye) to the usual standard doses of ICG for assessing blood flow during surgery.

Who is the study for?

This trial is for patients who are scheduled to have intestinal resection surgery. It's not suitable for pregnant individuals or those with kidney problems.Check my eligibility

What is being tested?

The study is testing the use of tiny doses of a dye called ICG compared to regular doses, to see how well blood flows through the colon during surgery.See study design

What are the potential side effects?

ICG may cause allergic reactions, including anaphylaxis. Other side effects can include nausea, vomiting, and skin rashes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for or have had surgery to remove part of my intestines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 30 days post operatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 30 days post operatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days post operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

ability to assess perfusion

Trial Design

2Treatment groups

Active Control

Group I: regular dose ICGActive Control1 Intervention

Group II: micro dose icgActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Shanglei LiuLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participating in this clinical trial?

"Individuals between 18 and 80 years old who exhibit perfusion-related issues are eligible for participation in this study, with a total enrollment capacity of 20 participants."

Answered by AI

Are participants currently being actively enrolled in this research study?

"Indeed, information from clinicaltrials.gov indicates that this research is presently seeking volunteers. This study was initially listed on November 1st, 2023, with the most recent update having taken place on February 3rd, 2024. The aim is to enroll a total of 20 participants at one designated site."

Answered by AI

Are participants aged 65 and older being sought for enrollment in this medical study?

"Recruitment for this study targets individuals over 18 years old but under the age of 80."

Answered by AI

What is the current sample size of patients involved in this clinical investigation?

"Indeed, information from clinicaltrials.gov indicates that recruitment for this trial is ongoing. The trial was initially posted on November 1st, 2023 and last modified on February 3rd, 2024. It aims to enroll 20 participants at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Microdosing ICG for Serial Colonic Perfusion Study During Surgery

Shanglei Liu 2023. "Microdosing ICG for Serial Colonic Perfusion Study During Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06254833.

All > Paid Studies San Diego